Skip to main content
. 2022 Mar 10;10(3):414. doi: 10.3390/vaccines10030414

Figure 3.

Figure 3

Production of IgM and IgG in serum, and IgA in mucosal surface antibodies from the first and second doses, simulating a first exposure to the pathogen and its immune memory. The stimulation of antibody IgA has been demonstrated after 1st dose vaccination [46]. Third dose guarantees to remain protected after six months. Design by: Carlos U. Torres-Estrella.